Description

Introducing Montaler-LC: Dual Relief with Montelukast 4mg and Levocetirizine Hydrochloride 2.5mg Suspension

Comprehensive Allergy and Asthma Relief: Montaler-LC combines 4mg of Montelukast, a leukotriene receptor antagonist, with 2.5mg of Levocetirizine Hydrochloride, a second-generation antihistamine, for effective management of allergy symptoms and asthma.

Targeted Action: Montelukast reduces bronchoconstriction and inflammation, while Levocetirizine blocks histamine receptors to alleviate symptoms like sneezing, itching, watery eyes, and runny nose.

Prolonged Symptom Control: Montaler-LC provides sustained relief, improving quality of life for those suffering from allergies and asthma.

Minimal Sedation: Unlike older antihistamines, Levocetirizine in Montaler-LC minimizes sedative effects, making it suitable for daytime use without affecting alertness.

Convenient Suspension Form: The easy-to-administer suspension ensures accurate dosing, particularly beneficial for those who have difficulty swallowing tablets.

Clinical Trust: Supported by clinical research, Montaler-LC is trusted for its efficacy and safety in managing allergic and asthmatic conditions.

Manufacturing Excellence: Anevay Pharmaceuticals manufactures Montaler-LC under stringent quality standards, ensuring pharmaceutical integrity and reliable relief.

Choose Montaler-LC for dual-action, comprehensive relief from allergy and asthma symptoms.